QMENTA Welcomes Roy Davis to Its Board of Advisors and as Board Observer
Barcelona, June 12, 2025 – QMENTA, a leading innovator in advanced neuroimaging data and AI-powered solutions for neuroscience, is proud to announce that Roy Davis has joined the company's Board of Advisors and will serve as a Board Observer.
Roy brings decades of global leadership in the healthcare and life sciences industries, having held a senior executive role with Johnson & Johnson (J&J) until his retirement in January 2012. His last position at J&J was Corporate Vice President of Business Development worldwide, where he was responsible for new business creation and acquisition strategy. Concurrently, he served as President of Johnson & Johnson Development Corporation (J&J’s venture capital group) and was the creator of Red Script Ventures, LLC (J&J's business accelerator). His extensive experience includes serving as Company Group Chairman, Johnson & Johnson and Worldwide Franchise Chairman, Medical Diagnostics, overseeing a significant portion of J&J's medical device business. Mr. Davis also founded Veridex LLC, a new company within J&J that produced award-winning cancer diagnostics products. Following his 28-year career with J&J, Mr. Davis has continued to contribute his expertise, serving on the Innovations Advisory Board for the Cleveland Clinic and the Advisory Board for the Wake Forest Institute for Regenerative Medicine, in addition to advising strategy firms and various diagnostic startup companies. His deep knowledge in driving global growth strategies, organizational transformation, and strategic innovation will provide QMENTA with invaluable guidance as the company continues its expansion and impact in the neuroimaging and AI space.
"We are thrilled to welcome Roy Davis to the QMENTA family," said Vesna Prchkovska, CEO of QMENTA. "His unique perspective and proven track record in life sciences innovation will help guide us as we scale our operations and deepen our collaborations with clinical researchers and life sciences companies worldwide."
Roy joins at a particularly important time as QMENTA accelerates its partnerships with biopharma and top institutions to enable more efficient, data-driven decision-making in brain research and clinical trials.
"I'm proud to contribute to QMENTA's vision of being the driving force behind making brain diseases a thing of the past," said Roy Davis. "QMENTA's platform has the potential to significantly impact how neurological conditions are studied and treated."
About QMENTA
QMENTA is a cloud-based platform that empowers the healthcare and life sciences sectors to analyze and manage brain imaging data at scale using AI. With a mission to accelerate neurological research, QMENTA works with leading institutions and biopharma organizations around the world.
For media inquiries, please contact:
Orlando Marin
Director of Marketing, QMENTA
orlando.marin@qmenta.com